Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Mylan NV Ord Shs (MYL)

Mylan NV Ord Shs (MYL)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
15.86 +0.31 (+1.99%) 11/16/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 15.86 unch (unch) -
Financial Summary for Mon, Nov 16th, 2020
Mylan, Inc. was incorporated in Pennsylvania in 1970. The Company and its subsidiaries comprise a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and branded generic pharmaceuticals, specialty pharmaceuticals and active pharmaceutical ingredients ('API'). The Compapny has two reportable segments, the Generics Segment and the Specialty Segment. The principal markets for the Generics Segment products are proprietary and ethical pharmaceutical wholesalers and distributors, drug store chains, drug manufacturers, institutions, and public and governmental agencies primarily within the United States ('U.S.') and Canada, Europe, the Middle East and Africa, and Australia, Japan, India and New Zealand. The Generics Segment also focuses on developing API with non-infringing processes to partner with generic manufacturers in regulated markets such as the U.S. and the European Union ('EU') at market formation. The principal market for the Specialty Segment is pharmaceutical wholesalers and distributors primarily in the U.S. Its specialty pharmaceutical business is conducted through Dey, which competes primarily in the respiratory, severe allergy and psychiatry markets. Dey's products are primarily branded specialty nebulized, injectable and transdermal products for life-threatening conditions. Currently, Mylan markets more than 900 different products covering a vast array of therapeutic categories, to consumers in more than 140 countries and territories across the globe. It offers a range of dosage forms and delivery systems, including oral solids, topicals, liquids and semi-solids, as well as some which are difficult to formulate and manufacture and typically have longer product life cycles than traditional generic pharmaceuticals, including high potency formulations, steriles, injectables, transdermal patches, controlled release and respiratory delivery products. Mylan utilizes a global approach to managing relationships with its suppliers. Matrix provides Mylan with significant vertical integration opportunities that have been significantly enhanced with the purchase of the former Merck Generics business. Its primary competitors include other generic companies (both major multinational generic drug companies and various local generic drug companies) and branded drug companies that continue to sell or license branded pharmaceutical products after patent expirations and other statutory expirations.
(Values in U.S. Thousands) Dec, 2019 Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015
Sales 11,500,500 11,433,900 11,907,700 11,076,900 9,429,300
Sales Growth +0.58% -3.98% +7.50% +17.47% +22.15%
Net Income 16,800 352,500 696,000 480,000 847,600
Net Income Growth -95.23% -49.35% +45.00% -43.37% -8.80%
(Values in U.S. Thousands) Dec, 2019 Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015
Total Assets 31,255,500 32,734,900 35,806,301 34,726,199 22,267,699
Total Assets Growth -4.52% -8.58% +3.11% +55.95% +40.17%
Total Liabilities 19,371,699 20,567,801 22,498,699 23,608,600 12,501,900
Total Liabilities Growth -5.82% -8.58% -4.70% +88.84% -0.86%
(Values in U.S. Thousands) Dec, 2019 Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015
Operating Cash Flow 1,803,700 2,341,700 2,064,800 2,047,200 2,008,500
Operating Cash Flow Growth -22.97% +13.41% +0.86% +1.93% +97.92%
Net Cash Flow 101,800 19,400 -706,700 -237,200 1,010,500
Change in Net Cash Flow +424.74% +102.75% -197.93% -123.47% +1,635.71%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals